Free shipping on all orders over $ 500

AG490

Cat. No. M1646
AG490 Structure
Synonym:

Tyrphostin AG490

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 30  USD30 In stock
25mg USD 50  USD50 In stock
50mg USD 86  USD86 In stock
100mg USD 120  USD120 In stock
200mg USD 210  USD210 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

AG490 (Tyrphostin AG490) is a selective inhibitor of EGF receptor tyrosine kinase with an IC50 values of 2 and 13.5 μM for EGFR and ErbB2 respectively. AG490 is also a JAK3/STAT, JAK3/AP-1 and JAK3/MAPK signaling pathway inhibitor and also blocks JAK3 autophosphorylation. AG-490 significantly inhibits the constitutive activation of Stat3 in MOPC, MPC11, and S194 cells, leading to dramatic dose-dependent apoptosis. AG-490 (100 μM) inhibits Akt phosphorylation, inhibits the activation of nuclear factor-κB, and causes the activation of GSK-3β, leading to the reduction of c-Myc. AG-490 (50 μM) can induce apoptosis of imatinib-resistant BaF3 cells expressing T315I and E255K mutants of Bcr-Abl.

Product Citations
Customer Product Validations & Biological Datas
Source Med Sci Monit (2018). Figure 5. AG490 (Abmole Bioscience)
Method DCFH-DA assays
Cell Lines Raji cells
Concentrations 5 μM
Incubation Time 24 h, 36 h, 48 h, and 72 h
Results A result that was consistent with the effect of the JAK2/STAT3 signaling pathway inhibitor AG490 (P>0.05).
Source Med Sci Monit (2018). Figure 4. AG490 (Abmole Bioscience)
Method Annexin V-FITC/PI staining
Cell Lines Raji cells
Concentrations 5 μM
Incubation Time 24 h, 36 h, 48 h, and 72 h
Results According to the results of Annexin V-FITC/PI staining (Figure 4A), the HSP70 siRNA group (55.2±3.1%) and AG490 group (60.8±4.2%) showed a remarkably higher cell apoptosis rate than the Blank group (14.5±1.3%) and NC siRNA group.
Source Med Sci Monit (2018). Figure 3. AG490 (Abmole Bioscience)
Method MTT assay
Cell Lines Raji cells
Concentrations 5 μM
Incubation Time 24 h, 36 h, 48 h, and 72 h
Results As displayed by the MTT assay (Figure 3A), both HSP70 siRNA and AG490 could effectively reduce the proliferation of Raji cells (24 h, 36 h, 48 h, and 72 h) (all P<0.05), and no significant difference was found between the Blank group and NC siRNA group regarding Raji cell proliferation at different time points.
Source Med Sci Monit (2018). Figure 2. AG490 (Abmole Bioscience)
Method Western blotting
Cell Lines Raji cells
Concentrations 5 μM
Incubation Time 24 h
Results As shown by the results of Western blotting (Figure 2), AG490 down-regulated the expression of p-JAK2 and p-STAT3.
Source Nutr Res (2018). Figure 4. AG490 (AbMole BioScience, Houston, TX, USA)
Method Cell viability assay
Cell Lines THP-1 cells
Concentrations 10 μM
Incubation Time 24 h
Results p-STAT3 protein levels were repressed by folic acid and AG490, and the trend for repression was consistent with p-JAK2.
Source China Tropical Medicine (2017). Figure 5~6. AG490 (Abmole Bioscience, Shanghai, China)
Method
Cell Lines THP-1 cell
Concentrations 10 μmol/L
Incubation Time 30 min
Results The expression of NF-κB p65 protein in p-JAK2, p-STAT3 and nucleus was significantly lower than that in hypoxia group (P <0.05), while the expression of JAK2 and STAT3 The protein expression did not affect.
Source China Tropical Medicine (2017). Figure 1~4. AG490 (Abmole Bioscience, Shanghai, China)
Method
Cell Lines THP-1 cell
Concentrations 10 μmol/L
Incubation Time 30 min
Results The secretion and mRNA expression of IL-1β and TNF-α were significantly lower than those of hypoxia group (P <0.05), and the difference was statistically significant (P <0.05)
Source Int J Mol Med (2017) . Figure 6. AG490 (Abmole Bioscience, Houston, TX, USA)
Method qRT-PCR
Cell Lines Fibroblast-like synoviocytes (FLS)
Concentrations 25 μM
Incubation Time 24 h
Results Treatment with matrine, AG490, or matrine+AG490 markedly increased the mRNA expression of Bax and caspase-3, and decreased expression of Bcl-2 (P<0.01 vs. CIA alone).
Source Int J Mol Med (2017) . Figure 5. AG490 (Abmole Bioscience, Houston, TX, USA)
Method Western blot
Cell Lines Fibroblast-like synoviocytes (FLS)
Concentrations 25 μM
Incubation Time 24 h
Results Protein expression levels of p-JAK2, p-STAT1 and p-STAT3 in FLS isolated after 24 h of drug treatment were only faintly detectable in the control group, and markedly higher in the CIA group (P<0.01 vs. control; Fig. 5).
Source Int J Mol Med (2017) . Figure 4. AG490 (Abmole Bioscience, Houston, TX, USA)
Method propidium iodide (PI) staining and flow cytometry
Cell Lines Fibroblast-like synoviocytes (FLS)
Concentrations 25 μM
Incubation Time 24 h
Results All drug treatments resulted in signifcantly higher apoptosis rates than that observed for the CIA group (P<0.01; matrine, 20.10±0.77%; AG490, 20.42±0.91%; matrine+AG490, 25.11±1.00%).
Source Int J Mol Med (2017) . Figure 3. AG490 (Abmole Bioscience, Houston, TX, USA)
Method propidium iodide (PI) staining and flow cytometry
Cell Lines Fibroblast-like synoviocytes (FLS)
Concentrations 25 μM
Incubation Time 24 h
Results Compared with the CIA group, the percentages of FLS in the S phase were significantly decreased in cells treated with matrine, the specifc JAK2 inhibitor AG490 (inhibits phosphorylation of STAT1/3 in RA-FLS), or both for 24 h (P<0.01; Fig. 3).
Protocol (for reference only)
Cell Experiment
Cell lines ALL cells
Preparation method cell proliferation assay as described previously
Concentrations 0~50μM
Incubation time 16 h
Animal Experiment
Animal models ALL cells tumour xenograft SCID mice
Formulation DMSO
Dosages 0.85mg/kg +0.5mg/kg daily
Administration i.p.
Chemical Information
Molecular Weight 294.30
Formula C17H14N2O3
CAS Number 133550-30-8
Solubility (25°C) DMSO ≥45 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Fernandez-Sanchez et al. Curr Med Chem. AG490 Promotes HIF-1α Accumulation by Inhibiting Its Hydroxylation.

[2] Davoodi-Semiromi et al. J Clin Immunol. Tyrphostin AG490 Agent Modestly but Significantly Prevents Onset of Type 1 in NOD Mouse; Implication of Immunologic and Metabolic Effects of a Jak-Stat Pathway Inhibitor.

Related JAK Products
A-005

A-005 is a potentially first-in-class, brain-penetrating TYK2 allosteric inhibitor for studies related to neuroinflammatory and neurodegenerative diseases.

Tyrosine Protein Kinase JAK 2 (Phospho-Tyr8, 9)

Tyrosine Protein Kinase JAK 2 (Phospho-Tyr8, 9) is a peptide corresponding to amino acids 475 to 491 of mouse JAK2.

JAK2/FLT3-IN-1 TFA

JAK2/FLT3-IN-1 (TFA) is a potent and orally active dual JAK2/FLT3 inhibitor with IC50 values of 0.7 nM, 4 nM, 26 nM and 39 nM for JAK2, FLT3, JAK1 and JAK3, respectively.

ZT55

ZT55 is an orally active and highly-selective JAK2 inhibitor with an IC50 value of 0.031 μM.

ZM39923

ZM39923 is a JAK3 inhibitor, with a pIC50 of 7.1; ZM39923 also potently inhibits tissue transglutaminase (TGM2) with an IC50 of 10 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: AG490, Tyrphostin AG490 supplier, JAK, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.